Well, you have to understand that people are starting to care less and less about "the next big iron ore stock".AGO is becoming a bottom drawer 10-15 year stock, it's no longer a junior prospective explorer.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling